HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Historical Portfolio Holders from Q3 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Debt / NOTE 1.000% 8/1
Principal, excl. options Q2 2024
24B
Holdings value Q2 2024
$700M
Value change Q2 2024
-$15.3M
Grand Portfolio weight change Q2 2024
0%
Number of holders
70
Number of buys Q2 2024
23
Number of sells Q2 2024
-30
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q2 $24B $700M -$15.3M $1.11 71
2024 Q1 $18.9B $641M -$1.98B $0.97 71
2023 Q4 $18.9B $646M +$16.4M $0.93 71
2023 Q3 $15.8B $640M +$640M $0.94 64